Temozolomide plus thalidomide in patients with advanced melanoma: Results of a dose-finding trial
Antineoplastic Combined Chemotherapy Protocols
The combination of temozolomide and thalidomide was well tolerated and had antitumor activity in patients with advanced melanoma, including elderly patients over 70 years old.
Digital Object Identifier (DOI)
Additional Document Info
has global citation frequency